276 related articles for article (PubMed ID: 22298263)
41. Challenges in the Diagnosis and Assessment of Psoriatic Arthritis.
Ogdie A; Lindsay CA; Mease PJ; Duffin KC; Rosen CF; Siebert S
J Rheumatol; 2022 Jun; 49(6 Suppl 1):64-67. PubMed ID: 35428713
[TBL] [Abstract][Full Text] [Related]
42. GRAPPA Trainees Symposium 2009: a report from the GRAPPA 2009 annual meeting.
Coates LC; Ritchlin CT
J Rheumatol; 2011 Mar; 38(3):526-9. PubMed ID: 21362780
[TBL] [Abstract][Full Text] [Related]
43. GRAPPA Patient Research Partner Network: Update to the GRAPPA 2020 Annual Meeting.
O'Sullivan DP; Steinkoenig I
J Rheumatol Suppl; 2021 Jun; 97():64. PubMed ID: 34074671
[TBL] [Abstract][Full Text] [Related]
44. The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set.
Leung YY; Orbai AM; Ogdie A; Coates LC; de Wit M; Callis Duffin K; Eder L; Gladman DD; Goel N; Mease PJ; Strand V; FitzGerald O; Tillett W
J Rheumatol Suppl; 2019 Jun; 95():33-37. PubMed ID: 31154402
[TBL] [Abstract][Full Text] [Related]
45. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis.
Coates LC; FitzGerald O; Merola JF; Smolen J; van Mens LJJ; Bertheussen H; Boehncke WH; Callis Duffin K; Campbell W; de Wit M; Gladman D; Gottlieb A; James J; Kavanaugh A; Kristensen LE; Kvien TK; Luger T; McHugh N; Mease P; Nash P; Ogdie A; Rosen CF; Strand V; Tillett W; Veale DJ; Helliwell PS
Arthritis Rheumatol; 2018 Mar; 70(3):345-355. PubMed ID: 29193765
[TBL] [Abstract][Full Text] [Related]
46. The path forward to biomarker discovery in psoriatic disease: a report from the GRAPPA 2010 annual meeting.
Gladman DD; Ritchlin CT; Fitzgerald O
J Rheumatol; 2012 Feb; 39(2):434-6. PubMed ID: 22298275
[TBL] [Abstract][Full Text] [Related]
47. The Patient Research Partner Network Matures: A Report from the GRAPPA 2017 Annual Meeting.
Goel N; O'Sullivan D; de Wit M; Lindsay CA; Bertheussen H; Latella J; Chau J; MacDonald R; Grieb S; Steinkoenig I; Campbell W
J Rheumatol Suppl; 2018 Jun; 94():52-53. PubMed ID: 29858356
[TBL] [Abstract][Full Text] [Related]
48. Report of the Skin Research Workgroups From the IDEOM Breakout at the GRAPPA 2022 Annual Meeting.
Zundell MP; Woodbury MJ; Lee K; Perez-Chada LM; Armstrong AW; Strand V; Merola JF; Gottlieb AB
J Rheumatol; 2023 Nov; 50(Suppl 2):47-50. PubMed ID: 37453734
[TBL] [Abstract][Full Text] [Related]
49. GRAPPA 2021 Treatment Recommendations for Psoriatic Arthritis.
Soriano ER; Coates LC; Kavanaugh A
J Rheumatol; 2023 Nov; 50(Suppl 2):31-32. PubMed ID: 37419619
[TBL] [Abstract][Full Text] [Related]
50. Report of the Skin Research Working Groups from the GRAPPA 2021 Annual Meeting.
Yousif JE; Merola JF; Perez-Chada LM; Zagona-Prizio C; Armstrong AW; Ogdie A; Shin S; Gottlieb AB
J Rheumatol; 2022 Jun; 49(6 Suppl 1):40-43. PubMed ID: 35365577
[TBL] [Abstract][Full Text] [Related]
51. International Treatment Recommendations Update: A Report from the GRAPPA 2016 Annual Meeting.
Coates LC; Chandran V; Ogdie A; O'Sullivan D; Brooke M; Steinkoenig I; Mease PJ; Ritchlin CT; Kavanaugh A
J Rheumatol; 2017 May; 44(5):684-685. PubMed ID: 28461525
[TBL] [Abstract][Full Text] [Related]
52. Practical Assessment of Psoriasis Clinical Severity in both Clinical Trials and Clinical Practice Settings: A Report from the GRAPPA 2016 Annual Meeting.
Merola JF; Gottlieb AB
J Rheumatol; 2017 May; 44(5):691-692. PubMed ID: 28461528
[TBL] [Abstract][Full Text] [Related]
53. Proceedings of the 2021 GRAPPA-Collaborative Research Network (CRN) Meeting.
Stober C; McInnes IB; Raychaudhuri S; Mease PJ; Pennington SR; Scher JU; Chandran V; Armstrong AW; Wit M; Cauli A; Jadon DR; Löve TJ; Ogdie A; O'Sullivan D; van Mens LJJ; Ritchlin CT; FitzGerald O
J Rheumatol; 2022 Jun; 49(6 Suppl 1):57-63. PubMed ID: 35365578
[TBL] [Abstract][Full Text] [Related]
54. Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN) Survey: Benefits and Challenges of Combined Rheumatology-dermatology Clinics.
Okhovat JP; Ogdie A; Reddy SM; Rosen CF; Scher JU; Merola JF
J Rheumatol; 2017 May; 44(5):693-694. PubMed ID: 28461529
[TBL] [Abstract][Full Text] [Related]
55. Report of the Skin Research Workgroups from the GRAPPA 2018 Annual Meeting.
Perez-Chada LM; Merola JF; Armstrong AW; Gottlieb AB
J Rheumatol Suppl; 2019 Jun; 95():28-32. PubMed ID: 31154401
[TBL] [Abstract][Full Text] [Related]
56. Dermatology screening tools: project update from the GRAPPA 2012 annual meeting.
Gladman DD; Helliwell PS; Khraishi M; Callis Duffin K; Mease PJ
J Rheumatol; 2013 Aug; 40(8):1425-7. PubMed ID: 23908538
[TBL] [Abstract][Full Text] [Related]
57. Strategies for biomarker development in psoriatic disease: a report from the GRAPPA 2010 annual meeting.
Ritchlin CT
J Rheumatol; 2012 Feb; 39(2):423-6. PubMed ID: 22298272
[TBL] [Abstract][Full Text] [Related]
58. Presidential Round Table: A Report from the GRAPPA Annual Meeting.
Gladman DD; Mease PJ; Boehncke WH; Helliwell PS; Callis Duffin K
J Rheumatol; 2016 May; 43(5):986-9. PubMed ID: 27134275
[TBL] [Abstract][Full Text] [Related]
59. Young-GRAPPA (Y-GRAPPA) at the 2022 GRAPPA Annual Meeting: One Year in Y-GRAPPA. Where Do We Stand, Where Do We Go?
Ayan G; Coras R; Grynszpan R; Herrera S; Jethwa H; Johnsson HJ; Silva DLF; van Mens L; Mulder MLM; Simon D; Vivekanantham A; Proft F
J Rheumatol; 2023 Nov; 50(Suppl 2):58-60. PubMed ID: 37453733
[TBL] [Abstract][Full Text] [Related]
60. Psoriasis and Psoriatic Arthritis Video Project 2010: a report from the GRAPPA annual meeting.
Callis Duffin K; Mease PJ
J Rheumatol; 2011 Mar; 38(3):562-3. PubMed ID: 21362788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
